A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

GWP42004

The total dose administered within any 24-hour interval will be two capsules (typically 12 hours apart).

DRUG

Placebo

The total dose administered within any 24-hour interval will be two capsules (typically 12 hours apart).

Trial Locations (25)

130083

Gagiu D. Remus Cabinet Medical Individual, Târgovişte

410159

Grandmed SRL, Oradea

430123

Cabinet Medical Individual Diabet Nutritie si Boli Metabolice, Maramures

440055

Spitalul Judetean de Urgente Satu Mare, Satu Mare

500365

Diabol SRL, Brasov

540142

Mediab SRL Diabet Zaharat, Târgu Mureş

550245

Spitalul Clinic Judetean de Urgenta Sibiu, Sibiu

700547

Consultmed SRL, Iași

010507

Nicodiab SRL, Bucharest

010825

"Spitalul Universitar de Urgenta Militar Central Dr. Carol Davila", Bucharest

020475

Institutul National de Diabet, Bucharest

020614

Centrul Medical 'Sanatatea Ta' SRL, Bucharest

021107

ArtMedical Clinic, Bucharest

050538

Societatea Civila Medicala dr. Paveliu, Bucharest

S40 4TF

Avondale Surgery, Chesterfield

HU3 2JZ

Hull and East Yorkshire Hospitals NHS Trust, Hull

M6 8HD

Salford Royal NHS Foundation Trust, Salford

LE5 4QF

University Hospitals of Leicester NHS Trust, Leicester

L9 7AL

Aintree University Hospitals NHS Foundation Trust, Liverpool

YO32 5UA

Strensall Medical Practice, York

OX3 9DU

Churchill Hospital, Oxford

SN14 6GT

Hathaway Surgery, Chippenham

BA12 9AA

Avenue Surgery, Warminster

BA3 2UH

St Chad's Surgery, Bath

E1 1BB

Barts and The London NHS Trust, London

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY